Recruiting studies: Multiple Myeloma Of Bone

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06988020 A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820 At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860 Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
NA · 1 location(s) · Spine Centre of Southern Denmark · NCT04533217 Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilizat
EARLY_Phase 1 · 2 location(s) · Rutgers, The State University of New Jersey · NCT04211259 National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199 Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease
NA · 7 location(s) · Christoffer Johansen · NCT05444348 Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
NA · 9 location(s) · University of Southern California · NCT03858205 Mosaic Trial for Stem Cell Transplant Recipients
NA · 3 location(s) · Northwestern University · NCT06960993 Personalized NK Cell Therapy in CBT
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT02727803 The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044 Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-
Phase 1 · 8 location(s) · Newave Pharmaceutical Inc · NCT04771572 A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Phase 1/Phase 2 · 104 location(s) · Sumitomo Pharma America, Inc. · NCT04988555 Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients W
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06904066 Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Phase N/A · 1 location(s) · Cancer Support Community, Research and Training Institute, P · NCT02333604 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · 20 location(s) · University Hospital, Clermont-Ferrand · NCT04935684 Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma
NA · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT05996367 Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Phase N/A · 1 location(s) · Shanxi Bethune Hospital · NCT07514052 High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523 Feasibility of a Multi-omics Platform for Hematological Malignancies
NA · 1 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT07445438 Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825 Collection of Tissue Samples for Cancer Research
Phase N/A · 17 location(s) · National Cancer Institute (NCI) · NCT00900198 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741 Allo HSCT Using RIC and PTCy for Hematological Diseases
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05805605 Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07214324 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Phase N/A · 142 location(s) · Center for International Blood and Marrow Transplant Researc · NCT01351545 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Phase N/A · 7 location(s) · Dana-Farber Cancer Institute · NCT02269592

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.